Analytical Data
-
基因名
TARC
- Application
-
别名
TARC；SCYA17；TARC；C-C motif chemokine 17
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q92583
-
表达区间
24-94aa
-
氨基酸序列
ARGTNVGRECCLEYFKGAIPLRKLKTWYQTSEDCSRDAIVFVTVQGRAIC SDPNNKRVKNAVKYLQSLERS
-
分子量
81 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TARC (Thymus and Activation-Regulated Chemokine), also known as CCL17, is a chemokine involved in immune responses and the recruitment of T cells to sites of inflammation. Its role in various diseases, including asthma, allergies, and cancer, has drawn significant research interest. TARC's overexpression in these conditions highlights its potential as a biomarker for disease severity and therapeutic target. The study of TARC recombinant proteins has gained momentum as researchers seek to understand its molecular mechanisms and interactions within the immune system. By expressing TARC in a recombinant system, scientists can produce large quantities of the protein for functional assays, structural studies, and potential therapeutic applications. Furthermore, understanding the structure-function relationship of TARC can aid in the development of targeted therapies that modulate its activity, providing new insights into treating immunological disorders. The exploration of TARC-recombinant proteins not only enhances our comprehension of its biological significance but also opens avenues for innovative treatments that harness the chemokine's properties in modulating immune responses.
